|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-05
|
$234,166
|
$18,733
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-12
|
$1,200,734
|
$600,367
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Facilitating Positive Adaptation to Breast Cancer
|
5R01CA064710-12
|
$449,588
|
$44,959
|
ANTONI, MICHAEL
|
UNIVERSITY OF MIAMI CORAL GABLES
|
|
T Cell Alternative p38 Activation Pathway
|
Z01 BC 010774
|
$431,955
|
$107,989
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$10,294
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$33,432
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
2U10CA052667-18
|
$787,595
|
$15,752
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-29S1
|
$628
|
$31
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
3U10CA037429-24S1
|
$464,405
|
$9,288
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA027057-29
|
$262,397
|
$13,120
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-29
|
$9,490,764
|
$474,538
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
7U10CA037429-24
|
$16,768,272
|
$335,365
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$219,608
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
|
5R01CA108970-04
|
$290,964
|
$218,223
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Role of PKR in Growth Regulation
|
5R01CA086431-10
|
$323,212
|
$323,212
|
Barber, Glen
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$18,805
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Nanoparticle peptide-based therapy for melanoma
|
1R43CA132464-01
|
$166,488
|
$41,622
|
Bedu-Addo, Frank
|
PDS BIOTECHNOLOGY CORPORATION
|
|
The Gulf Coast MBCCOP
|
7U10CA128536-02
|
$539,869
|
$5,399
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-02
|
$162,047
|
$40,512
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-33
|
$452,395
|
$36,192
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$11,989
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,350,223
|
$135,022
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Natural Killer Cell Growth and Development
|
5R01CA041268-23
|
$337,399
|
$253,049
|
BIRON, CHRISTINE
|
BROWN UNIVERSITY
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
5R01CA072669-12
|
$298,185
|
$98,401
|
Blazar, Bruce
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Expression and Function of Tob in T Lymphocytes
|
7R01CA104596-04
|
$318,352
|
$15,918
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
$9,615
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
The function and regulation of histocompatibility antigen 60 in cancer
|
1K08CA128893-01A1
|
$127,170
|
$127,170
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$896
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-33
|
$3,753,703
|
$37,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
IL-15 Characterization Through Experimental Immunology
|
5R01CA068458-13
|
$271,102
|
$81,331
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The role of cellular miRNA in Epstein-Barr virus oncogenesis
|
1F32CA130469-01A2
|
$52,898
|
$13,225
|
Cameron, Jennifer
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
|
5R01CA100226-05
|
$262,798
|
$52,560
|
CAMPBELL, KERRY
|
INSTITUTE FOR CANCER RESEARCH
|
|
Cancer Research for the Ozarks
|
5U10CA045560-20
|
$681,391
|
$6,814
|
CAROLLA, ROBERT
|
OZARK HEALTH VENTURES, LLC
|
|
A program of immune-based treatments for cancer
|
2K24CA093670-06
|
$178,300
|
$89,150
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$1,159
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$2,472
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$927
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$765
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$40,057
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Survivin & Interferon-alpha as Cancer Vaccine Therapy in Pancreatic Cancer
|
1K23CA128927-01A1
|
$136,080
|
$68,040
|
CHANG, DAVID
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
|
5R01CA097085-07
|
$363,450
|
$36,345
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
Myeloid suppressor cell-mediated immune suppression of tumor specific T cells
|
5R01CA109322-03
|
$262,923
|
$13,146
|
CHEN, SHU-HSIA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Pathogenesis of Hepatitis B Virus in Transgenic Mice
|
5R01CA040489-23
|
$792,726
|
$198,182
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
Total relevant funding to Interferon for this search: $35,442,662
|